Experienced technology executive Michael Artinger has been named managing director of the Research Translation Group for Applied Innovation at the University of California, Irvine.
The Research Translation Group serves as a liaison for faculty and staff across all UCI departments. The group will assist in developing strong alliances with industry, ensuring that federal, state, and private investment in UCI research has the greatest possible global impact.
Before joining UCI Applied Innovation, Artinger most recently served as the vice president for marketing & strategic partnering at ViroCyt, an innovative analytical instrument company acquired by Sartorius in 2016. His technology focus includes the life sciences, renewable energy, and clean-tech sectors.
Artinger’s past operational experience encompasses senior positions in marketing, strategic planning, alliance management, and product development, which includes serving as vice president for commercial operations at InDevR, director of Fitzsimons BioBusiness Partners, and president/CEO at Nanodisc.
“Michael adds significant experience and vision to UCI Applied Innovation as it continues to fulfill its mission of initiating and accelerating best practices-driven collaborative engagement of industry and faculty innovators,” says Richard Sudek, Applied Innovation’s executive director and chief innovation officer. “His efforts will be essential for translating and commercializing opportunities generated through the UCI research enterprise.”
Artinger’s expertise includes an in-depth knowledge of company formation, equity, and grant fundraising, as well as mergers and acquisitions. He earned a doctorate degree in developmental & cell biology, bachelor’s degree in applied ecology from UCI, and completed a postdoctoral fellowship at Harvard Medical School and Massachusetts General Hospital.
“Leading technology commercialization at UCI is a once-in-a-lifetime opportunity,” he says. “I’m thrilled to be back on campus after 21 years working in industry and look forward to applying my experience transforming innovation into products that have significant global impact.”